Avanos Medical (AVNS) Non-Current Deferred Tax Liability (2014 - 2026)

Avanos Medical has disclosed Non-Current Deferred Tax Liability across 13 years of filings, most recently posting $5.6 million for Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability changed 0.0% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (changed 0.0% YoY), while the FY2025 annual figure was $6.1 million, down 83.01% from the prior year.
• Non-Current Deferred Tax Liability came in at $5.6 million for Q1 2026 at Avanos Medical, down from $6.1 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $71.1 million in Q4 2022 to a low of $5.6 million in Q1 2025.
• Average Non-Current Deferred Tax Liability over 5 years is $27.1 million, with a median of $23.9 million recorded in 2024.
• Year-over-year, Non-Current Deferred Tax Liability soared 560.71% in 2022 and plunged 83.01% in 2025.
• Over 5 years, Non-Current Deferred Tax Liability stood at $71.1 million in 2022, then dropped by 0.56% to $70.7 million in 2023, then sank by 49.22% to $35.9 million in 2024, then sank by 83.01% to $6.1 million in 2025, then retreated by 8.2% to $5.6 million in 2026.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $5.6 million in Q1 2026, $6.1 million in Q4 2025, and $6.3 million in Q3 2025.